Filling the need for trusted information on national health issues…

J&J Receives $117M Grant From E.U.-Supported Innovative Medicines Initiative For Ebola Vaccine Efforts

Associated Press: Johnson & Johnson Ebola groups get $117M in funding
“Johnson & Johnson is working with a slew of organizations to speed up development of an Ebola vaccine, and the company said Friday that a European health organization awarded them $117 million…” (1/16).

Financial Times: J&J receives €100m E.U. injection for Ebola vaccine development
“J&J and its partners are the main beneficiaries of a €215m funding package from the E.U.-backed Innovative Medicines Initiative announced on Friday to support development and manufacturing of vaccines and diagnostic tools for Ebola…” (Ward, 1/16).

Wall Street Journal: J&J Gets Grant to Speed Up Ebola Vaccine
“…The grants will go toward clinical trials and production of J&J’s experimental vaccine and a campaign to raise awareness of the vaccination. In October, J&J committed $200 million to developing the treatment and has since been looking for funding partners…” (Dulaney, 1/16).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.